News | Breast Density | September 12, 2023

A leading website on the topic of dense breasts has announced that the second annual #WorldDenseBreastDay will be held on September 27, 2023. Plans for the 24-hour Social Media Education Marathon follow news of the FDA’s new “dense breast” reporting requirement going into effect September 2024

#WorldDenseBreastDay will be held on September 27, 2023

#WorldDenseBreastDay will be held on September 27, 2023. Plans for the 24-hour Social Media Education Marathon follow news of the FDA’s new “dense breast” reporting requirement going into effect September 2024. Image courtesy of DenseBreast-info.org


September 12, 2023 — DenseBreast-info.org (DBI), a leading website on the topic of dense breasts, has announced that the second annual #WorldDenseBreastDay will be held on September 27, 2023. Plans for the 24-hour Social Media Education Marathon follow news of the FDA’s new “dense breast” reporting requirement going into effect September 2024. Other countries are following suit, and the European Society of Breast Imaging is now recommending that European women also be informed about their breast density.

The purpose of this worldwide one-day education marathon, according to its sponsor is to raise awareness about the screening and risk implications of dense breasts and share medically-sourced educational resources.

Building on the success of DBI’s 2022 inaugural event, #WorldDenseBreastDay will reach tens of thousands of patients, health providers and health organizations across the globe, noted the September 12 statement. The 2022 event engaged participants in 37 countries with over 8.6 million posts read. This year, in 2023, over 100 social media posts, including videos and dynamic visuals, in both English and Spanish, will kick-off #WorldDenseBreastDay beginning at midnight U.S.A./Eastern and running for 24 hours. Posts will include links to educational tools on the DenseBreast-info.org website addressing what breast density is, why it matters, and screening options for women with dense breasts. Medical providers, health organizations, researchers and the general public are encouraged to participate.

“The FDA Final Rule requires women be told if their breasts are dense or not dense and the European Society of Breast Imaging now recommends that European women be informed of their individual breast density. It is crucial to get ahead of what the educational needs will be,” said JoAnn Pushkin, Executive Director, DBI. She added, “DBI is the most comprehensive resource on the topic and this event has expanded globally to meet the growing need in the U.S.A. and beyond for medically-sourced information on the topic.”

“Forty percent of women of mammography age have dense breasts and mammograms miss about 40% of cancers in dense breasts,” said Wendie Berg, MD, PhD, FACR, Professor, Department of Radiology, University of Pittsburgh School of Medicine, and DBI Chief Scientific Advisor. “Many women with dense breasts would benefit from additional screening after their mammogram. The type of additional screening will depend on specific breast density and other risk factors as well as patient factors such as claustrophobia. Educational events like #WorldDenseBreastDay are essential to provide women and their health providers with the information needed to decide on optimal screening,” she added.

Growing from 40,000 visits in 2016, DenseBreast-info.org projects 750,000+ visits in 2023. DBI features provider resources and patient educational tools. DenseBreast-info, Inc., is a 501(c)(3) non-profit supported by unrestricted educational grants and donations from: GE HealthCare, Bayer Healthcare, Bayer AG, Myriad Genetics, Hologic, Delphinus Medical Technologies, Volpara Health, Beekley Medical, iCAD, CMR Naviscan, Bracco Diagnostics, and Vaso Healthcare.

Find more information at: www.DenseBreast-info.org

Related content: 

VIDEO: FDA Update on the US National Density Reporting Standard - A Discussion on the Final Rule   

One on One … with Wendie Berg, MD, PhD, FACR, FSBI   

Task Force Issues New Draft Recommendation Statement on Screening for Breast Cancer   

Creating Patient Equity: A Breast Density Legislative Update   


Related Content

News | Mammography

April 16, 2024 — The Radiological Society of North America (RSNA) and GE HealthCare announced their collaboration to ...

Time April 16, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
Videos | Breast Imaging

Don't miss ITN's latest "One on One" video interview with AAWR Past President and American College of Radiology (ACR) ...

Time April 15, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Dose Management

April 11, 2024 — Prelude Corporation (PreludeDx), a leader in precision diagnostics for early-stage breast cancer ...

Time April 11, 2024
arrow
News | Mammography

April 11, 2024 — Volpara Health Technologies Ltd., a global leader in software for the early detection and prevention of ...

Time April 11, 2024
arrow
News | Society of Breast Imaging (SBI)

April 11, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced today ...

Time April 11, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...

Time April 10, 2024
arrow
News | Ultrasound Imaging

April 9, 2024 — A new Society of Radiologists in Ultrasound (SRU) expert consensus statement to improve endometriosis ...

Time April 09, 2024
arrow
Subscribe Now